Douglas Eric Raines, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Etomidate | 36 | 2022 | 185 | 14.190 |
Why?
|
| Hypnotics and Sedatives | 24 | 2021 | 1193 | 5.640 |
Why?
|
| Receptors, GABA-A | 27 | 2022 | 624 | 4.130 |
Why?
|
| Anesthetics, Intravenous | 9 | 2018 | 395 | 2.860 |
Why?
|
| Adrenal Cortex | 9 | 2018 | 134 | 2.710 |
Why?
|
| Anesthetics, Inhalation | 24 | 2018 | 573 | 2.470 |
Why?
|
| Anesthetics | 10 | 2021 | 525 | 2.080 |
Why?
|
| Receptors, Nicotinic | 22 | 2012 | 495 | 2.060 |
Why?
|
| Receptors, Serotonin, 5-HT3 | 9 | 2013 | 45 | 1.660 |
Why?
|
| Steroid 11-beta-Hydroxylase | 3 | 2018 | 20 | 1.580 |
Why?
|
| Xenopus laevis | 26 | 2020 | 965 | 1.530 |
Why?
|
| Diazepam | 3 | 2022 | 215 | 1.500 |
Why?
|
| Pyrroles | 8 | 2016 | 1120 | 1.460 |
Why?
|
| Propofol | 9 | 2022 | 607 | 1.370 |
Why?
|
| Receptors, GABA | 4 | 2020 | 312 | 1.280 |
Why?
|
| Anesthetics, General | 8 | 2012 | 151 | 1.020 |
Why?
|
| Rats, Sprague-Dawley | 22 | 2019 | 8113 | 0.970 |
Why?
|
| gamma-Aminobutyric Acid | 10 | 2022 | 1140 | 0.960 |
Why?
|
| Ion Channel Gating | 12 | 2015 | 428 | 0.930 |
Why?
|
| Flumazenil | 3 | 2021 | 84 | 0.920 |
Why?
|
| Reflex | 5 | 2019 | 375 | 0.900 |
Why?
|
| GABA-A Receptor Agonists | 5 | 2011 | 86 | 0.890 |
Why?
|
| Binding, Competitive | 5 | 2020 | 1140 | 0.880 |
Why?
|
| GABA Antagonists | 3 | 2017 | 119 | 0.790 |
Why?
|
| Reflex, Righting | 4 | 2018 | 19 | 0.790 |
Why?
|
| Dose-Response Relationship, Drug | 23 | 2020 | 10737 | 0.790 |
Why?
|
| Naphthalenes | 2 | 2020 | 197 | 0.760 |
Why?
|
| Isoflurane | 11 | 2008 | 384 | 0.740 |
Why?
|
| GABA-A Receptor Antagonists | 3 | 2020 | 59 | 0.740 |
Why?
|
| Rats | 25 | 2019 | 23717 | 0.730 |
Why?
|
| Structure-Activity Relationship | 15 | 2018 | 3051 | 0.730 |
Why?
|
| Larva | 10 | 2018 | 511 | 0.710 |
Why?
|
| Nicotinic Antagonists | 6 | 2012 | 94 | 0.700 |
Why?
|
| Torpedo | 19 | 2011 | 170 | 0.680 |
Why?
|
| GABA Modulators | 2 | 2020 | 108 | 0.680 |
Why?
|
| Oocytes | 16 | 2018 | 1168 | 0.650 |
Why?
|
| Nicotinic Agonists | 6 | 2002 | 265 | 0.640 |
Why?
|
| Alkanes | 3 | 2003 | 39 | 0.600 |
Why?
|
| Propanolamines | 1 | 2018 | 163 | 0.570 |
Why?
|
| Animals | 74 | 2022 | 168800 | 0.560 |
Why?
|
| Adrenocorticotropic Hormone | 3 | 2018 | 618 | 0.560 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 8 | 2012 | 904 | 0.540 |
Why?
|
| Steroids | 2 | 2019 | 934 | 0.520 |
Why?
|
| Halothane | 5 | 2007 | 200 | 0.510 |
Why?
|
| Pulmonary Alveoli | 8 | 2008 | 665 | 0.490 |
Why?
|
| Adrenal Cortex Diseases | 2 | 2014 | 13 | 0.450 |
Why?
|
| Serotonin 5-HT3 Receptor Antagonists | 2 | 2013 | 23 | 0.440 |
Why?
|
| Excitatory Amino Acid Antagonists | 5 | 2020 | 451 | 0.420 |
Why?
|
| Biotransformation | 4 | 2018 | 165 | 0.420 |
Why?
|
| Patch-Clamp Techniques | 9 | 2012 | 924 | 0.410 |
Why?
|
| Kinetics | 15 | 2012 | 6273 | 0.400 |
Why?
|
| Hydrocarbons, Aromatic | 4 | 2009 | 23 | 0.400 |
Why?
|
| Electroencephalography | 6 | 2019 | 6279 | 0.400 |
Why?
|
| Membrane Potentials | 8 | 2012 | 1085 | 0.390 |
Why?
|
| Carboxylic Acids | 1 | 2011 | 91 | 0.370 |
Why?
|
| Infusions, Intravenous | 5 | 2015 | 2227 | 0.370 |
Why?
|
| Binding Sites | 7 | 2021 | 6001 | 0.370 |
Why?
|
| Carbon | 1 | 2014 | 673 | 0.360 |
Why?
|
| Endotoxemia | 1 | 2012 | 198 | 0.350 |
Why?
|
| Serotonin | 4 | 2007 | 1045 | 0.340 |
Why?
|
| Electrophysiology | 7 | 2010 | 1263 | 0.340 |
Why?
|
| Benzene Derivatives | 1 | 2009 | 51 | 0.340 |
Why?
|
| Zebrafish | 4 | 2022 | 3035 | 0.330 |
Why?
|
| GABA Agonists | 2 | 2014 | 106 | 0.310 |
Why?
|
| Hydrocarbons, Halogenated | 2 | 2009 | 21 | 0.290 |
Why?
|
| Lipopolysaccharides | 1 | 2015 | 2213 | 0.290 |
Why?
|
| Dansyl Compounds | 4 | 2000 | 19 | 0.280 |
Why?
|
| Fatty Alcohols | 1 | 2007 | 22 | 0.280 |
Why?
|
| Seizures | 2 | 2019 | 2997 | 0.280 |
Why?
|
| Alcohols | 3 | 2005 | 94 | 0.280 |
Why?
|
| Spectrometry, Fluorescence | 7 | 2006 | 694 | 0.280 |
Why?
|
| Corticosterone | 3 | 2013 | 301 | 0.280 |
Why?
|
| Pentobarbital | 1 | 2007 | 153 | 0.280 |
Why?
|
| Lipid Bilayers | 4 | 2000 | 376 | 0.270 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 1890 | 0.270 |
Why?
|
| Information Management | 1 | 2007 | 100 | 0.260 |
Why?
|
| Hydrocortisone | 4 | 2021 | 1832 | 0.260 |
Why?
|
| Half-Life | 3 | 2012 | 645 | 0.260 |
Why?
|
| Receptors, Serotonin | 1 | 2007 | 209 | 0.260 |
Why?
|
| Anesthesia | 4 | 2014 | 1595 | 0.250 |
Why?
|
| Dopamine | 3 | 2007 | 1582 | 0.250 |
Why?
|
| Diazomethane | 3 | 2011 | 38 | 0.250 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 3 | 2020 | 390 | 0.250 |
Why?
|
| Xenopus | 5 | 2018 | 709 | 0.250 |
Why?
|
| Cerebrospinal Fluid | 1 | 2008 | 540 | 0.250 |
Why?
|
| Ligands | 8 | 2020 | 3274 | 0.240 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2005 | 150 | 0.230 |
Why?
|
| Methyl Ethers | 1 | 2006 | 196 | 0.230 |
Why?
|
| Hospital Information Systems | 1 | 2007 | 395 | 0.230 |
Why?
|
| Muscle, Skeletal | 1 | 2019 | 4959 | 0.230 |
Why?
|
| Cations | 1 | 2004 | 239 | 0.220 |
Why?
|
| Immobilization | 4 | 2008 | 226 | 0.210 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2007 | 388 | 0.210 |
Why?
|
| Quaternary Ammonium Compounds | 3 | 2000 | 204 | 0.210 |
Why?
|
| Electric Organ | 6 | 2002 | 55 | 0.210 |
Why?
|
| Ketamine | 2 | 2020 | 527 | 0.200 |
Why?
|
| Solubility | 6 | 2014 | 1077 | 0.200 |
Why?
|
| Octanols | 4 | 2011 | 25 | 0.200 |
Why?
|
| Ion Channels | 6 | 2010 | 1044 | 0.200 |
Why?
|
| Recovery of Function | 1 | 2013 | 2971 | 0.200 |
Why?
|
| Dogs | 2 | 2019 | 3824 | 0.200 |
Why?
|
| Models, Animal | 2 | 2020 | 2120 | 0.200 |
Why?
|
| Sepsis | 1 | 2015 | 2603 | 0.180 |
Why?
|
| Aprotinin | 1 | 2001 | 93 | 0.180 |
Why?
|
| Fluorobenzenes | 3 | 2007 | 179 | 0.180 |
Why?
|
| Photoaffinity Labels | 3 | 2011 | 85 | 0.180 |
Why?
|
| Drug Antagonism | 1 | 2020 | 50 | 0.180 |
Why?
|
| Drug Discovery | 2 | 2019 | 1065 | 0.180 |
Why?
|
| Rana pipiens | 2 | 2018 | 64 | 0.180 |
Why?
|
| Membranes | 4 | 2002 | 164 | 0.180 |
Why?
|
| Documentation | 1 | 2007 | 911 | 0.170 |
Why?
|
| Porphyria, Hepatoerythropoietic | 1 | 1999 | 8 | 0.170 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 18321 | 0.170 |
Why?
|
| DNA, Complementary | 4 | 2005 | 1984 | 0.170 |
Why?
|
| Photosensitivity Disorders | 1 | 1999 | 79 | 0.160 |
Why?
|
| HEK293 Cells | 3 | 2020 | 4263 | 0.160 |
Why?
|
| Proteins | 3 | 2006 | 5995 | 0.160 |
Why?
|
| Synaptic Membranes | 3 | 1998 | 88 | 0.160 |
Why?
|
| Hemostatics | 1 | 2001 | 247 | 0.150 |
Why?
|
| Hypnosis, Anesthetic | 1 | 2018 | 7 | 0.150 |
Why?
|
| Stereoisomerism | 3 | 2014 | 612 | 0.150 |
Why?
|
| Receptors, Muscarinic | 1 | 1998 | 156 | 0.150 |
Why?
|
| Allosteric Regulation | 5 | 2015 | 425 | 0.150 |
Why?
|
| Liver Transplantation | 2 | 2001 | 2417 | 0.150 |
Why?
|
| Male | 26 | 2019 | 363935 | 0.150 |
Why?
|
| Cytokines | 1 | 2012 | 7426 | 0.130 |
Why?
|
| Fluorescent Dyes | 3 | 2001 | 1928 | 0.130 |
Why?
|
| Eisenmenger Complex | 1 | 1996 | 26 | 0.130 |
Why?
|
| Azirines | 2 | 2012 | 30 | 0.130 |
Why?
|
| Chemistry, Physical | 3 | 2002 | 152 | 0.130 |
Why?
|
| Drug Interactions | 3 | 2007 | 1419 | 0.130 |
Why?
|
| Anesthetics, Dissociative | 1 | 2016 | 81 | 0.130 |
Why?
|
| Chemical Phenomena | 3 | 2002 | 483 | 0.130 |
Why?
|
| GABA Agents | 1 | 2015 | 41 | 0.130 |
Why?
|
| Protein Conformation | 6 | 2006 | 3946 | 0.130 |
Why?
|
| Electrophysiological Phenomena | 1 | 2017 | 308 | 0.130 |
Why?
|
| Blood Pressure | 1 | 2011 | 8532 | 0.130 |
Why?
|
| Convulsants | 1 | 2015 | 70 | 0.130 |
Why?
|
| Molecular Structure | 4 | 2012 | 1881 | 0.130 |
Why?
|
| Light | 2 | 2012 | 1358 | 0.120 |
Why?
|
| Benzodiazepines | 1 | 2021 | 1136 | 0.120 |
Why?
|
| Movement | 2 | 2017 | 1461 | 0.120 |
Why?
|
| Butanols | 1 | 1995 | 19 | 0.120 |
Why?
|
| Phenobarbital | 1 | 2015 | 192 | 0.120 |
Why?
|
| Postural Balance | 2 | 2010 | 637 | 0.120 |
Why?
|
| Fluorescence | 4 | 1999 | 751 | 0.120 |
Why?
|
| Lethal Dose 50 | 1 | 2014 | 70 | 0.120 |
Why?
|
| Thromboembolism | 1 | 2001 | 1001 | 0.120 |
Why?
|
| Female | 21 | 2020 | 396233 | 0.120 |
Why?
|
| Phosphatidylcholines | 5 | 1998 | 403 | 0.110 |
Why?
|
| Anesthesia, Local | 1 | 1996 | 277 | 0.110 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2014 | 273 | 0.110 |
Why?
|
| Humans | 39 | 2021 | 766117 | 0.110 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1999 | 713 | 0.110 |
Why?
|
| Cycloparaffins | 1 | 1993 | 12 | 0.110 |
Why?
|
| Indicators and Reagents | 1 | 2014 | 456 | 0.110 |
Why?
|
| Molecular Conformation | 1 | 2014 | 539 | 0.110 |
Why?
|
| Butanes | 2 | 2003 | 5 | 0.110 |
Why?
|
| Cyclopropanes | 3 | 2004 | 436 | 0.100 |
Why?
|
| Methanol | 1 | 1993 | 91 | 0.100 |
Why?
|
| Mephobarbital | 1 | 2012 | 7 | 0.100 |
Why?
|
| 1-Butanol | 2 | 2007 | 13 | 0.100 |
Why?
|
| Brain | 5 | 2016 | 27177 | 0.100 |
Why?
|
| Azo Compounds | 1 | 2012 | 115 | 0.100 |
Why?
|
| Membrane Lipids | 1 | 1993 | 240 | 0.100 |
Why?
|
| Depression, Chemical | 1 | 2011 | 186 | 0.100 |
Why?
|
| Hospital Costs | 1 | 2018 | 955 | 0.100 |
Why?
|
| Esters | 1 | 2012 | 213 | 0.090 |
Why?
|
| Blood Pressure Monitors | 1 | 1991 | 33 | 0.090 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 1651 | 0.090 |
Why?
|
| Drug Stability | 1 | 2011 | 289 | 0.090 |
Why?
|
| Chromatography, Gas | 2 | 2008 | 150 | 0.090 |
Why?
|
| Heme | 1 | 2013 | 316 | 0.090 |
Why?
|
| Spinal Cord | 3 | 2008 | 1811 | 0.090 |
Why?
|
| Deep Sedation | 1 | 2012 | 119 | 0.090 |
Why?
|
| Electron Spin Resonance Spectroscopy | 5 | 1995 | 158 | 0.090 |
Why?
|
| Area Under Curve | 1 | 2014 | 1638 | 0.090 |
Why?
|
| Models, Chemical | 2 | 2006 | 607 | 0.090 |
Why?
|
| Injections, Spinal | 2 | 2008 | 318 | 0.090 |
Why?
|
| Drug Costs | 1 | 2018 | 1195 | 0.080 |
Why?
|
| Anesthesia, General | 2 | 1996 | 1187 | 0.080 |
Why?
|
| Esterases | 1 | 2009 | 89 | 0.080 |
Why?
|
| Hydroxides | 1 | 1989 | 46 | 0.080 |
Why?
|
| Hemodynamics | 2 | 2010 | 4188 | 0.080 |
Why?
|
| Monitoring, Intraoperative | 2 | 1996 | 946 | 0.080 |
Why?
|
| Hexanols | 2 | 2007 | 6 | 0.080 |
Why?
|
| Electrochemistry | 2 | 2002 | 142 | 0.080 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 2010 | 161 | 0.080 |
Why?
|
| Motor Activity | 3 | 2009 | 2711 | 0.080 |
Why?
|
| Random Allocation | 1 | 2013 | 2395 | 0.080 |
Why?
|
| Potassium Chloride | 1 | 2008 | 227 | 0.070 |
Why?
|
| Acetylcholine | 3 | 1999 | 628 | 0.070 |
Why?
|
| Volatilization | 1 | 2007 | 75 | 0.070 |
Why?
|
| Anesthesia, Inhalation | 1 | 1989 | 220 | 0.070 |
Why?
|
| Algorithms | 7 | 2005 | 14066 | 0.070 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2011 | 1527 | 0.070 |
Why?
|
| Heart | 1 | 2021 | 4419 | 0.070 |
Why?
|
| Pulmonary Embolism | 1 | 2001 | 2596 | 0.070 |
Why?
|
| 1-Octanol | 1 | 2007 | 7 | 0.070 |
Why?
|
| 1-Propanol | 1 | 2007 | 15 | 0.070 |
Why?
|
| Osmolar Concentration | 1 | 2008 | 655 | 0.070 |
Why?
|
| Time Factors | 6 | 2018 | 40108 | 0.070 |
Why?
|
| Receptors, Cholinergic | 3 | 2008 | 243 | 0.070 |
Why?
|
| Behavior, Animal | 1 | 2014 | 1867 | 0.070 |
Why?
|
| Microinjections | 1 | 2007 | 319 | 0.070 |
Why?
|
| Pharmaceutical Preparations | 1 | 1994 | 1084 | 0.070 |
Why?
|
| Benzophenones | 1 | 2006 | 58 | 0.070 |
Why?
|
| Cell Line, Transformed | 1 | 2007 | 858 | 0.070 |
Why?
|
| Drug Synergism | 2 | 2008 | 1754 | 0.070 |
Why?
|
| Interleukin-10 | 1 | 2012 | 1181 | 0.070 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2006 | 143 | 0.060 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2007 | 870 | 0.060 |
Why?
|
| Chloroform | 1 | 2005 | 31 | 0.060 |
Why?
|
| Interleukin-1beta | 1 | 2012 | 1028 | 0.060 |
Why?
|
| Benzene | 1 | 2006 | 106 | 0.060 |
Why?
|
| Ethanol | 2 | 2007 | 1326 | 0.060 |
Why?
|
| Protein Binding | 1 | 2018 | 9301 | 0.060 |
Why?
|
| Anticonvulsants | 1 | 2015 | 1920 | 0.060 |
Why?
|
| Spin Labels | 4 | 1995 | 334 | 0.060 |
Why?
|
| Health Expenditures | 1 | 2018 | 2389 | 0.060 |
Why?
|
| Models, Biological | 5 | 2009 | 9445 | 0.060 |
Why?
|
| Water | 1 | 2011 | 1416 | 0.060 |
Why?
|
| RNA, Messenger | 3 | 2010 | 12775 | 0.060 |
Why?
|
| Liposomes | 4 | 1995 | 786 | 0.060 |
Why?
|
| Drug Design | 1 | 2010 | 1040 | 0.060 |
Why?
|
| Lipid Metabolism | 1 | 1993 | 1893 | 0.060 |
Why?
|
| Stearic Acids | 2 | 1995 | 56 | 0.060 |
Why?
|
| Potassium | 1 | 2008 | 1312 | 0.060 |
Why?
|
| Analgesia | 1 | 2008 | 461 | 0.060 |
Why?
|
| Protons | 1 | 1989 | 1073 | 0.050 |
Why?
|
| Biophysical Phenomena | 2 | 1995 | 318 | 0.050 |
Why?
|
| Flurothyl | 1 | 2002 | 10 | 0.050 |
Why?
|
| Chlorofluorocarbons | 1 | 2002 | 12 | 0.050 |
Why?
|
| Sodium | 1 | 2008 | 1591 | 0.050 |
Why?
|
| Catheterization | 1 | 2008 | 1426 | 0.050 |
Why?
|
| Biophysics | 2 | 1995 | 375 | 0.050 |
Why?
|
| Protein Structure, Secondary | 1 | 2006 | 1211 | 0.050 |
Why?
|
| Cyclobutanes | 1 | 2002 | 57 | 0.050 |
Why?
|
| Electric Stimulation | 1 | 2007 | 1736 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2007 | 1716 | 0.050 |
Why?
|
| Administration, Inhalation | 1 | 2005 | 1154 | 0.050 |
Why?
|
| Hydrogen Bonding | 1 | 2002 | 290 | 0.050 |
Why?
|
| Orosomucoid | 1 | 2001 | 45 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2012 | 3227 | 0.050 |
Why?
|
| Models, Molecular | 4 | 2012 | 5382 | 0.050 |
Why?
|
| Microelectrodes | 1 | 2003 | 305 | 0.050 |
Why?
|
| Fluorocarbons | 1 | 2007 | 499 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2010 | 1677 | 0.050 |
Why?
|
| Reaction Time | 1 | 2007 | 2086 | 0.050 |
Why?
|
| Cysteine | 1 | 2006 | 898 | 0.050 |
Why?
|
| Cystectomy | 1 | 2005 | 603 | 0.040 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2007 | 1195 | 0.040 |
Why?
|
| Motion | 2 | 1995 | 782 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2009 | 1882 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2014 | 5089 | 0.040 |
Why?
|
| Cholinergic Agents | 1 | 2000 | 97 | 0.040 |
Why?
|
| Tetralogy of Fallot | 1 | 2005 | 629 | 0.040 |
Why?
|
| Thermodynamics | 2 | 1995 | 577 | 0.040 |
Why?
|
| Phosphatidic Acids | 1 | 1998 | 50 | 0.040 |
Why?
|
| Lipids | 3 | 1994 | 3316 | 0.040 |
Why?
|
| Tennessee | 1 | 2018 | 123 | 0.040 |
Why?
|
| Choline | 1 | 2000 | 511 | 0.040 |
Why?
|
| Cell Line | 1 | 2011 | 15546 | 0.040 |
Why?
|
| RNA | 1 | 2007 | 2716 | 0.040 |
Why?
|
| Wound Healing | 1 | 2008 | 2795 | 0.040 |
Why?
|
| Enflurane | 1 | 1996 | 16 | 0.030 |
Why?
|
| Isomerism | 1 | 2015 | 197 | 0.030 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2018 | 261 | 0.030 |
Why?
|
| Inflammation | 1 | 2015 | 10860 | 0.030 |
Why?
|
| Phospholipids | 2 | 1993 | 776 | 0.030 |
Why?
|
| Protein Subunits | 2 | 2010 | 940 | 0.030 |
Why?
|
| Serum Albumin | 1 | 1998 | 673 | 0.030 |
Why?
|
| Pharmacology | 1 | 1994 | 97 | 0.030 |
Why?
|
| Anesthetics, Local | 1 | 2001 | 1005 | 0.030 |
Why?
|
| Gene Expression | 1 | 2007 | 7582 | 0.030 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2018 | 497 | 0.030 |
Why?
|
| Anesthesia, Epidural | 1 | 1996 | 232 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1996 | 1607 | 0.030 |
Why?
|
| Gases | 1 | 1994 | 205 | 0.030 |
Why?
|
| Models, Economic | 1 | 2018 | 716 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2017 | 65219 | 0.030 |
Why?
|
| Transfection | 1 | 2001 | 5739 | 0.030 |
Why?
|
| Labor, Obstetric | 1 | 1996 | 313 | 0.030 |
Why?
|
| Reflex, Abnormal | 1 | 1993 | 83 | 0.030 |
Why?
|
| Cattle | 2 | 2010 | 3801 | 0.030 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2005 | 2176 | 0.030 |
Why?
|
| Photochemical Processes | 1 | 2012 | 84 | 0.020 |
Why?
|
| Conscious Sedation | 1 | 1996 | 534 | 0.020 |
Why?
|
| Fibrinolytic Agents | 1 | 2001 | 2077 | 0.020 |
Why?
|
| Plant Oils | 1 | 2012 | 199 | 0.020 |
Why?
|
| Rotation | 1 | 1993 | 513 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 1993 | 578 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 14645 | 0.020 |
Why?
|
| Radioligand Assay | 1 | 2010 | 365 | 0.020 |
Why?
|
| Postoperative Care | 1 | 1996 | 1475 | 0.020 |
Why?
|
| Nerve Block | 1 | 1996 | 717 | 0.020 |
Why?
|
| Cholesterol | 1 | 1998 | 2902 | 0.020 |
Why?
|
| Delivery, Obstetric | 1 | 1996 | 948 | 0.020 |
Why?
|
| Equipment Failure | 1 | 1991 | 580 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2012 | 1751 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1993 | 2476 | 0.020 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2008 | 57 | 0.020 |
Why?
|
| Action Potentials | 1 | 2015 | 1834 | 0.020 |
Why?
|
| Static Electricity | 1 | 2008 | 258 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2001 | 6409 | 0.020 |
Why?
|
| Nitrous Oxide | 1 | 2008 | 166 | 0.020 |
Why?
|
| Receptors, Glutamate | 1 | 2008 | 228 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 2782 | 0.020 |
Why?
|
| Cesarean Section | 1 | 1996 | 1418 | 0.020 |
Why?
|
| Preoperative Care | 1 | 1996 | 2249 | 0.020 |
Why?
|
| Goats | 1 | 2007 | 166 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 1989 | 565 | 0.020 |
Why?
|
| Sodium Channels | 1 | 2008 | 339 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2001 | 18967 | 0.020 |
Why?
|
| Mice | 4 | 2015 | 81839 | 0.020 |
Why?
|
| Cell Membrane | 1 | 1995 | 3635 | 0.020 |
Why?
|
| Boston | 1 | 2018 | 9335 | 0.020 |
Why?
|
| Picrotoxin | 1 | 2004 | 61 | 0.010 |
Why?
|
| Middle Aged | 4 | 2018 | 223083 | 0.010 |
Why?
|
| Xenon | 1 | 2004 | 120 | 0.010 |
Why?
|
| Neurons | 1 | 2002 | 9521 | 0.010 |
Why?
|
| Survival Rate | 1 | 1996 | 12827 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 2001 | 291 | 0.010 |
Why?
|
| Adult | 3 | 2018 | 223139 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2008 | 3448 | 0.010 |
Why?
|
| Genetic Engineering | 1 | 2003 | 933 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2008 | 3561 | 0.010 |
Why?
|
| Aged | 3 | 2018 | 171219 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2009 | 6254 | 0.010 |
Why?
|
| Photochemistry | 1 | 1994 | 238 | 0.010 |
Why?
|
| Pregnancy | 1 | 1996 | 30233 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2010 | 5758 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2005 | 5300 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1996 | 42511 | 0.010 |
Why?
|
| Young Adult | 1 | 2018 | 59868 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 20137 | 0.010 |
Why?
|
| Risk Factors | 1 | 1996 | 74857 | 0.000 |
Why?
|
| Child | 1 | 1996 | 80573 | 0.000 |
Why?
|
| Adolescent | 1 | 1996 | 88819 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1996 | 81565 | 0.000 |
Why?
|
| Mice, Knockout | 1 | 2002 | 14456 | 0.000 |
Why?
|
| Research Design | 1 | 2001 | 6206 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 2002 | 22341 | 0.000 |
Why?
|